Filtros de búsqueda

Lista de obras de

A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer

artículo científico publicado en 2019

A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer

artículo científico publicado en 2019

Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer

artículo científico publicado en 2009

Capmatinib for the treatment of non-small cell lung cancer

artículo científico publicado en 2019

Current status of immune checkpoint inhibition in early-stage NSCLC

artículo científico publicado en 2019

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data

artículo científico publicado en 2020

Phenotype molding of stromal cells in the lung tumor microenvironment

artículo científico publicado en 2018

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

article

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung C

article

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer

artículo científico publicado en 2007

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2019

Will liquid biopsies become our fluid transition to personalized immunotherapy?

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda